Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CCI-779 Extension in Relapsing MS
NCT00228397Phase 2Completed
- Sponsor
- Pfizer
- Start
- Nov 2003
- Primary completion
- Nov 2005
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of temsirolimus in relapsing-remitting multiple sclerosis (RRMS), sponsored by Pfizer. Started Nov 2003; status: completed.
02
Drugs
temsirolimus
03
Conditions
relapsing-remitting multiple sclerosis (RRMS)
Beyond the preview
Go deeper on NCT00228397.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00228397.